Counteracting Data Bias and Class Imbalance-Towards a Useful and Reliable Retinal Disease Recognition System.
convolutional neural networks
deep learning
medical image classification
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
29 May 2023
29 May 2023
Historique:
received:
27
03
2023
revised:
22
05
2023
accepted:
25
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Multiple studies presented satisfactory performances for the treatment of various ocular diseases. To date, there has been no study that describes a multiclass model, medically accurate, and trained on large diverse dataset. No study has addressed a class imbalance problem in one giant dataset originating from multiple large diverse eye fundus image collections. To ensure a real-life clinical environment and mitigate the problem of biased medical image data, 22 publicly available datasets were merged. To secure medical validity only Diabetic Retinopathy (DR), Age-Related Macular Degeneration (AMD) and Glaucoma (GL) were included. The state-of-the-art models ConvNext, RegNet and ResNet were utilized. In the resulting dataset, there were 86,415 normal, 3787 GL, 632 AMD and 34,379 DR fundus images. ConvNextTiny achieved the best results in terms of recognizing most of the examined eye diseases with the most metrics. The overall accuracy was 80.46 ± 1.48. Specific accuracy values were: 80.01 ± 1.10 for normal eye fundus, 97.20 ± 0.66 for GL, 98.14 ± 0.31 for AMD, 80.66 ± 1.27 for DR. A suitable screening model for the most prevalent retinal diseases in ageing societies was designed. The model was developed on a diverse, combined large dataset which made the obtained results less biased and more generalizable.
Identifiants
pubmed: 37296756
pii: diagnostics13111904
doi: 10.3390/diagnostics13111904
pmc: PMC10253060
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
IEEE Trans Med Imaging. 2000 Mar;19(3):203-10
pubmed: 10875704
Invest Ophthalmol Vis Sci. 2015 Feb 03;56(3):1805-12
pubmed: 25650416
J Crit Care Med (Targu Mures). 2021 Aug 05;7(3):241-248
pubmed: 34722928
IEEE Trans Med Imaging. 2010 Jan;29(1):185-95
pubmed: 19822469
JAMA Ophthalmol. 2019 Mar 1;137(3):258-264
pubmed: 30629091
JAMA Ophthalmol. 2013 Mar;131(3):351-7
pubmed: 23494039
Mol Pharm. 2017 Dec 4;14(12):4462-4475
pubmed: 29096442
Sci Rep. 2022 Apr 8;12(1):5979
pubmed: 35395867
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882
Med Image Anal. 2020 Jan;59:101570
pubmed: 31630011
N Engl J Med. 2020 Apr 30;382(18):1687-1695
pubmed: 32286748
Lancet Digit Health. 2021 Aug;3(8):e486-e495
pubmed: 34325853
Arch Ophthalmol. 2007 Mar;125(3):406-10
pubmed: 17353416
PLoS One. 2017 Jun 22;12(6):e0179790
pubmed: 28640840
Br J Ophthalmol. 2001 Mar;85(3):261-6
pubmed: 11222327
J Med Imaging (Bellingham). 2017 Jan;4(1):014503
pubmed: 28217714
Comput Intell Neurosci. 2022 Apr 28;2022:5007111
pubmed: 35528343
Eye (Lond). 2019 Jul;33(7):1029-1031
pubmed: 30814654
Comput Biol Med. 2022 Jul;146:105648
pubmed: 35751184
Ophthalmology. 2020 Jan;127(1):85-94
pubmed: 31281057
PLoS One. 2014 Jun 02;9(6):e96814
pubmed: 24886780
J Gen Intern Med. 2004 May;19(5 Pt 1):460-5
pubmed: 15109345
IEEE Trans Pattern Anal Mach Intell. 2023 Apr;45(4):5314-5321
pubmed: 36094972
Biomed Eng Online. 2019 Mar 20;18(1):29
pubmed: 30894178
Br J Ophthalmol. 2022 Aug;106(8):1079-1086
pubmed: 33785508
J Clin Med. 2022 May 17;11(10):
pubmed: 35628958
BMJ. 1995 Oct 28;311(7013):1131-5
pubmed: 7580708
J Med Internet Res. 2021 Jul 13;23(7):e27822
pubmed: 34255681
Commun Med (Lond). 2021 Aug 23;1:25
pubmed: 34522916
JAMA Ophthalmol. 2019 Sep 01;137(9):987-993
pubmed: 31194246
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5200-5206
pubmed: 27701631